Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII

  1. Man Chu
  2. Taotao Li
  3. Bin Shen
  4. Xudong Cao
  5. Haoyu Zhong
  6. Luqing Zhang
  7. Fei Zhou
  8. Wenjuan Ma
  9. Haijuan Jiang
  10. Pancheng Xie
  11. Zhengzheng Liu
  12. Ningzheng Dong
  13. Ying Xu
  14. Yun Zhao
  15. Guoqiang Xu
  16. Peirong Lu
  17. Jincai Luo
  18. Qingyu Wu
  19. Kari Alitalo
  20. Gou Young Koh
  21. Ralf H Adams
  22. Yulong He  Is a corresponding author
  1. Soochow University, China
  2. Peking University, China
  3. University of Helsinki, Finland
  4. Institute of Basic Science and Korea Advanced Institute of Science and Technology, Republic of Korea
  5. Max-Planck-Institute for Molecular Biomedicine, Germany

Abstract

Mechanisms underlying the vein development remain largely unknown. Tie2 signaling mediates endothelial cell (EC) survival and vascular maturation and its activating mutations are linked to venous malformations. Here we show that vein formation are disrupted in mouse skin and mesentery when Tie2 signals are diminished by targeted deletion of Tek either ubiquitously or specifically in embryonic ECs. Postnatal Tie2 attenuation resulted in the degeneration of newly formed veins followed by the formation of haemangioma-like vascular tufts in retina and venous tortuosity. Mechanistically, Tie2 insufficiency compromised venous EC identity, as indicated by a significant decrease of COUP-TFII protein level, a key regulator in venogenesis. Consistently, angiopoietin-1 stimulation increased COUP-TFII in cultured ECs, while Tie2 knockdown or blockade of Tie2 downstream PI3K/Akt pathway reduced COUP-TFII which could be reverted by the proteasome inhibition. Together, our results imply that Tie2 is essential for venous specification and maintenance via Akt mediated stabilization of COUP-TFII.

Article and author information

Author details

  1. Man Chu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  2. Taotao Li

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  3. Bin Shen

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  4. Xudong Cao

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  5. Haoyu Zhong

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  6. Luqing Zhang

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  7. Fei Zhou

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1857-8831
  8. Wenjuan Ma

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  9. Haijuan Jiang

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  10. Pancheng Xie

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  11. Zhengzheng Liu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  12. Ningzheng Dong

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  13. Ying Xu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6689-7768
  14. Yun Zhao

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  15. Guoqiang Xu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  16. Peirong Lu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  17. Jincai Luo

    Laboratory of Vascular Biology, Institute of Molecular Medicine, Peking University, Beijing, China
    Competing interests
    No competing interests declared.
  18. Qingyu Wu

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    Competing interests
    No competing interests declared.
  19. Kari Alitalo

    Wihuri Research Institute, University of Helsinki, Helsinki, Finland
    Competing interests
    Kari Alitalo, Reviewing editor, eLife.
  20. Gou Young Koh

    Center for Vascular Research, Institute of Basic Science and Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea
    Competing interests
    No competing interests declared.
  21. Ralf H Adams

    Max-Planck-Institute for Molecular Biomedicine, Münster, Germany
    Competing interests
    No competing interests declared.
  22. Yulong He

    Cyrus Tang Hematology Center, Soochow University, Suzhou, China
    For correspondence
    yulong.he@mpi-muenster.mpg.de
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0099-3749

Funding

National Natural Science Foundation of China (91539101,31271530,31071263)

  • Yulong He

Ministry of Science and Technology of the People's Republic of China (2012CB947600)

  • Yulong He

Priority Program Development of Jiangsu Higher Education Institutions

  • Yulong He

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Elisabetta Dejana, FIRC Institute of Molecular Oncology, Italy

Ethics

Animal experimentation: Conditional mice with Tek gene targeted flox sites for gene deletion were generated by the National Resource Center for Mutant Mice, Nanjing University. All animal experiments were performed in accordance with the institutional guidelines of the Soochow and Nanjing University Animal Center (MARC-AP#YH2).

Version history

  1. Received: August 28, 2016
  2. Accepted: December 21, 2016
  3. Accepted Manuscript published: December 22, 2016 (version 1)
  4. Version of Record published: January 6, 2017 (version 2)

Copyright

© 2016, Chu et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,679
    views
  • 812
    downloads
  • 45
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Man Chu
  2. Taotao Li
  3. Bin Shen
  4. Xudong Cao
  5. Haoyu Zhong
  6. Luqing Zhang
  7. Fei Zhou
  8. Wenjuan Ma
  9. Haijuan Jiang
  10. Pancheng Xie
  11. Zhengzheng Liu
  12. Ningzheng Dong
  13. Ying Xu
  14. Yun Zhao
  15. Guoqiang Xu
  16. Peirong Lu
  17. Jincai Luo
  18. Qingyu Wu
  19. Kari Alitalo
  20. Gou Young Koh
  21. Ralf H Adams
  22. Yulong He
(2016)
Angiopoietin receptor Tie2 is required for vein specification and maintenance via regulating COUP-TFII
eLife 5:e21032.
https://doi.org/10.7554/eLife.21032

Share this article

https://doi.org/10.7554/eLife.21032

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Gang Xue, Xiaoyi Zhang ... Zhiyuan Li
    Research Article

    Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.

    1. Developmental Biology
    2. Evolutionary Biology
    Zhuqing Wang, Yue Wang ... Wei Yan
    Research Article

    Despite rapid evolution across eutherian mammals, the X-linked MIR-506 family miRNAs are located in a region flanked by two highly conserved protein-coding genes (SLITRK2 and FMR1) on the X chromosome. Intriguingly, these miRNAs are predominantly expressed in the testis, suggesting a potential role in spermatogenesis and male fertility. Here, we report that the X-linked MIR-506 family miRNAs were derived from the MER91C DNA transposons. Selective inactivation of individual miRNAs or clusters caused no discernible defects, but simultaneous ablation of five clusters containing 19 members of the MIR-506 family led to reduced male fertility in mice. Despite normal sperm counts, motility, and morphology, the KO sperm were less competitive than wild-type sperm when subjected to a polyandrous mating scheme. Transcriptomic and bioinformatic analyses revealed that these X-linked MIR-506 family miRNAs, in addition to targeting a set of conserved genes, have more targets that are critical for spermatogenesis and embryonic development during evolution. Our data suggest that the MIR-506 family miRNAs function to enhance sperm competitiveness and reproductive fitness of the male by finetuning gene expression during spermatogenesis.